These outcomes, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 help the strategy of targeting ACKR3 as a novel solution to modulate the opioid system, which could open new therapeutic avenues for opioid-related Diseases. All of our content is reviewed https://conolidine43209.glifeblog.com/26394844/the-definitive-guide-to-conolidine